ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
ResMed (NYSE: RMD) plans to release its financial and operational results for Q3 of fiscal year 2022 on April 28, 2022, post-market close. Following this, management will host a webcast to discuss the results and other relevant information. The webcast will be available internationally, with details for various time zones provided. A replay of the earnings call will be accessible approximately two hours post-webcast. ResMed focuses on innovative solutions for chronic diseases, impacting healthcare quality and costs.
- Scheduled earnings release for fiscal Q3 2022 indicates ongoing financial reporting consistency.
- Management's engagement with investors through a webcast demonstrates transparency and commitment.
- None.
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast.
Earnings webcast details:
| • | Location: | http://investor.resmed.com |
| • | Date: | Thursday, April 28, 2022 |
| • | Time: | 1:30 p.m. PDT / 4:30 p.m. EDT |
| • | International: | London, Thursday, April 28, 9:30 p.m. BST |
| Sydney, Friday, April 29, 6:30 a.m. AEST |
Please note that ResMed does not use outside phone lines to access the earnings call.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from April 28 until May 12 at:
| • | U.S.: +1 877.660.6853 |
| • | International: +1 201.612.7415 |
| • | Conference ID: 13727876 |
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed release its Q3 fiscal year 2022 earnings?
What time is the ResMed earnings webcast?
How can I access the ResMed earnings call replay?
What is ResMed's ticker symbol?
What type of solutions does ResMed provide?
